Investor List:

Top Pharmaceuticals Series B Investors in Israel (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Cris De Luca, Partner at Sanofi Ventures
Cris De Luca
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Israel, Investors in New York (NY), Investors in Europe, Investors in San Francisco (CA), Investors in Cambridge (MA)
Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in AR/VR (Series A), Investors in Medical Devices (Series A), Investors in AR/VR (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in AR/VR (Series A), Investors in Pharmaceuticals (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in AR/VR (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in AR/VR (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in IoT (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in IoT (Series B), Investors in Pharmaceuticals (Series B), Investors in AR/VR (Series B), Investors in IoT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in IoT (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Israel (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Ittai Harel, Managing Partner at Pitango Venture Capital
Ittai Harel
Pitango Venture Capital·Managing Partner
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in Israel
Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in AgTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in AgTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in AgTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Israel (Other Lists)
Photo of Ran Nussbaum, Managing Partner at Pontifax Venture Capital
Ran Nussbaum
Pontifax Venture Capital·Managing Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Israel
Photo of Jeremy Sohn, Managing Partner at P74 Ventures
Jeremy Sohn
P74 Ventures·Managing Partner
Sweet spot: $5.0M
Range: $500K - $10.0M
Investors in Europe, Investors in United Kingdom, Investors in Israel, Investors in United States
Photo of Eyal Inbal, Partner at 040 Capital
Eyal Inbal
040 Capital·Partner
Sweet spot: $10
Range: $1 - $500
Investors in Tel Aviv (Israel)
Investors in Pharmaceuticals (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Robotics (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in IoT (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in AutoTech (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in IoT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in AutoTech (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Health IT (Seed), Investors in DeepTech (Seed), Investors in IoT (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in AutoTech (Seed), Investors in AI (Seed), Investors in DeepTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in IoT (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in AutoTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Cybersecurity (Series A), Investors in AI (Series A), Investors in AutoTech (Series A), Investors in Medical Devices (Series A), Investors in DeepTech (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in Pharmaceuticals (Series A), Investors in IoT (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in AutoTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Robotics (Series B), Investors in DeepTech (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in IoT (Series B), Investors in Cybersecurity (Series B), Investors in AutoTech (Series B), Investors in AI (Series B), Investors in DeepTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in IoT (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Israel (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Ariyeh Ginsberg, Vice President at Tatum Goodman & Associates
Ariyeh Ginsberg
Sweet spot: $25.0M
Range: $5.0M - $1.0B
Investors in Israel
Get new data & insights delivered to your inbox